These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 33960976)

  • 21. Atrial fibrillation: profit from cardiac pacing?
    Yang A; Lüderitz B; Lewalter T
    Z Kardiol; 2005 Mar; 94(3):141-51. PubMed ID: 15747036
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Merits and limitations of the mode switching rate stabilization pacing algorithms in the implantable cardioverter defibrillator.
    Dijkman B; Wellens HJ
    J Interv Card Electrophysiol; 2001 Sep; 5(3):309-18. PubMed ID: 11500586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Leadless cardiac pacing systems: current status and future prospects.
    Beurskens NEG; Breeman KTN; Dasselaar KJ; Meijer AC; Quast ABE; Tjong FVY; Knops RE
    Expert Rev Med Devices; 2019 Nov; 16(11):923-930. PubMed ID: 31657945
    [No Abstract]   [Full Text] [Related]  

  • 24. [Mode-switching algorithms: programming and usefulness].
    Israel CW
    Herz; 2001 Feb; 26(1):2-17. PubMed ID: 11258106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advances in Cardiac Electrophysiology.
    Piccini JP; Russo AM; Sharma PS; Kron J; Tzou W; Sauer W; Park DS; Birgersdotter-Green U; Frankel DS; Healey JS; Hummel J; Koruth J; Linz D; Mittal S; Nair DG; Nattel S; Noseworthy PA; Steinberg BA; Trayanova NA; Wan EY; Wissner E; Zeitler EP; Wang PJ
    Circ Arrhythm Electrophysiol; 2022 Dec; 15(12):e009911. PubMed ID: 36441565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of bradycardia pacing and detection of ventricular fibrillation due to far-field atrial sensing in a triple chamber implantable cardioverter defibrillator.
    Vollmann D; Lüthje L; Görtler G; Unterberg C
    Pacing Clin Electrophysiol; 2002 Oct; 25(10):1513-6. PubMed ID: 12418750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Initial experience with a new balloon-guided single lead catheter for internal cardioversion of atrial fibrillation and dual chamber pacing.
    Plewan A; Valina C; Herrmann R; Alt E
    Pacing Clin Electrophysiol; 1999 Jan; 22(1 Pt 2):228-32. PubMed ID: 9990636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical experience with a dual-chamber implantable cardioverter defibrillator to treat atrial tachyarrhythmias.
    Gold MR; Sulke N; Schwartzman DS; Mehra R; Euler DE;
    J Cardiovasc Electrophysiol; 2001 Nov; 12(11):1247-53. PubMed ID: 11761411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
    Wilkoff BL;
    Card Electrophysiol Rev; 2003 Dec; 7(4):468-72. PubMed ID: 15071277
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atrial fibrillation reduces the atrial impedance amplitude during cardiac cycle: a novel detection algorithm to improve recognition of atrial fibrillation in pacemaker patients.
    Schmidt B; Asbach S; Schweika O; Zehender M; Bode C; Faber TS
    Europace; 2007 Sep; 9(9):812-6. PubMed ID: 17545214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of atrial antitachycardia functions for treating atrial fibrillation: observations in patients with a dual-chamber defibrillator.
    Ricci R; Pignalberi C; Santini M
    Card Electrophysiol Rev; 2003 Dec; 7(4):348-51. PubMed ID: 15071251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The results of pacing trials for the prevention and termination of atrial tachyarrhythmias: is there any evidence of therapeutic breakthrough?
    Savelieva I; Camm AJ
    J Interv Card Electrophysiol; 2003 Apr; 8(2):103-15. PubMed ID: 12766501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cardiac remodelling and function after cardiovascular implantable electronic devices implantation].
    Stanek A; Lelakowski J; Matusik PT
    Pol Merkur Lekarski; 2019 Apr; 46(274):187-189. PubMed ID: 31099767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Worldwide clinical experience with a new dual-chamber implantable cardioverter defibrillator system.
    Schoels W; Swerdlow CD; Jung W; Stein KM; Seidl K; Haffajee CJ;
    J Cardiovasc Electrophysiol; 2001 May; 12(5):521-8. PubMed ID: 11386511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. First worldwide clinical experience with a new dual chamber implantable cardioverter defibrillator. Advantages and complications. The Ventak AV II DR investigators.
    Sticherling C; Schaumann A; Klingenheben T; Hohnloser SH
    Europace; 1999 Apr; 1(2):96-102. PubMed ID: 11233190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proarrhythmic effect of automatic threshold testing algorithm in dual chamber devices.
    Larsen TR; Sargent D; Moyes M; Huizar JF; Tan AY; Ellenbogen KA; Kaszala K
    J Cardiovasc Electrophysiol; 2020 Aug; 31(8):2078-2085. PubMed ID: 32510718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. His-bundle pacing using dual-chamber cardioverter-defibrillator in patients with chronic atrial fibrillation: different pacing and sensing features.
    Sławuta A; Biały D; Zyśko D; Mazur G; Gajek J
    Acta Cardiol; 2017 Jun; 72(3):343-344. PubMed ID: 28636524
    [No Abstract]   [Full Text] [Related]  

  • 38. Technological Advances in Arrhythmia Management Applied to Adults With Congenital Heart Disease.
    Mondésert B; Nair K; McLeod CJ; Khairy P
    Can J Cardiol; 2019 Dec; 35(12):1708-1722. PubMed ID: 31813504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implantable cardioverter-defibrillators.
    Pinski SL; Fahy GJ
    Am J Med; 1999 Apr; 106(4):446-58. PubMed ID: 10225249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hybrid therapy of atrial fibrillation.
    Santini M; Pignalberi C; Ricci R; Calò L
    Ital Heart J; 2002 Oct; 3(10):571-8. PubMed ID: 12478814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.